Company Epic Corporation Other OTC
Equities
US29428L2051
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,370,080 | 21,370,080 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Epic Corp.
2454 North McMullen Booth Road Suite 713
33759, Clearwater
+512-873-2211
http://www.epiccor.comSector
1st Jan change | Capi. | |
---|---|---|
+64.92% | 10.11B | |
+57.48% | 2.31B | |
+52.06% | 486M | |
-52.06% | 456M | |
+163.23% | 456M | |
-57.65% | 307M | |
-62.51% | 142M | |
-.--% | 121M | |
-32.20% | 96.93M |
- Stock Market
- Equities
- EPOR Stock
- Stock
- Company Epic Corporation